Proliferation-quiescence control by integration of stress and mitogen signaling

通过整合应激和有丝分裂原信号传导来控制增殖-静止

• 批准号: 8766464
• 负责人: Sabrina Leigh Spencer
• 金额: $ 18.43万
• 依托单位: UNIVERSITY OF COLORADO
• 依托单位国家: 美国
• 财政年份: 2014
• 资助国家: 美国
• 起止时间: 2014-09-15 至 2017-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8766464
• 关键词: Activity Cycles; Affect; Biochemistry; Buffers; Cell Cycle; Cell Cycle Arrest; Cell Cycle Progression; Cell Cycle Regulation; Cell division; Cells; Commit; DNA Damage; DNA biosynthesis; Data; Dominant-Negative Mutation; Event; G0 Phase; Goals; Growth Factor; Incidence; Interphase; Lead; Life; Light; Link; MAP Kinase Gene; Malignant Neoplasms; Mediating; Metabolic; Mitogen-Activated Protein Kinase Inhibitor; Mitogens; Mitosis; Molecular; Monitor; Normal Cell; Outcome; Pathway interactions; Pharmaceutical Preparations; Phosphorylation; Phosphotransferases; Proliferating; Recovery; Regulation; Research; Signal Transduction; Somatic Cell; Stress; Testing; Therapeutic Intervention; Time; Uncertainty; Up-Regulation; Work; cancer cell; cancer type; cellular imaging; human CDK2 protein; inhibitor/antagonist; insight; interest; oncoprotein p21; public health relevance; repaired; sensor; small molecule; tumorigenic; ubiquitin-protein ligase

DESCRIPTION (provided by applicant): Entry into the cell cycle is deregulated in nearly all types of cancer, demonstrating the importance of the cellular decision to proliferate or remain quiescent. Despite this, the molecular events involved in a cell's committing to another round of cell division are not well defined. The overall goal of this proposal is to build a quantitative, dynamic, and mechanistic understanding of the proliferation-quiescence decision in normal, somatic cells. Specifically, I am interested in how cells integrate stress and growth factor signaling inputs at the end of the previous cell cycle to control the proliferative or quiescent fae after mitosis. Key to achieving this goal is my ability to monitor cell cycle events at the moleculr level in single, asynchronously cycling cells. I will make use of a new live-cell sensor that I developed that monitors Cyclin-dependent kinase 2 (CDK2) activity, a key driver of cell cycle progression. Cell cycle commitment is marked by a buildup of CDK2 activity, whereas quiescent cells lack CDK2 activity. My first aim will be to determine how the CDK inhibitor, p21, controls whether, after mitosis, cells immediately build up CDK2 activity and choose a proliferative fate or turn CDK2 activity off and choose a quiescent fate. My second aim will explore the dynamics with which DNA damage causes cell cycle arrest, how cells recover from this damage and resume cycling, and how DNA damage in one cell cycle affects the proliferation-quiescence decision in the next cycle. In my third aim, I seek to understand how growth factor signaling regulates the cell cycle machinery to drive proliferation and how mitogenic signals are integrated in G2/M of the previous cell cycle to influence the proliferative or quiescent fate of a cell. My ability to link upstream signal transduction events to the proliferation-quiescence outcome in single cells will provide valuable insight into this critical control point and may identify new targets that be exploited therapeutically for treating cancer.

描述（由申请人提供）：几乎所有类型的癌症都在输入细胞周期的情况下进行了管制，这证明了细胞繁殖或保持静止的重要性。尽管如此，细胞对另一轮细胞分裂的涉及的分子事件并未得到很好的定义。该提案的总体目标是建立对正常体细胞中增殖 - 质量决策的定量，动态和机械理解。具体而言，我对细胞在上一个细胞周期结束时如何整合压力和生长因子信号输入，以控制有丝分裂后的增殖或静止FAE。实现这一目标的关键是我能够在单个异步循环细胞中监测分子水平的细胞周期事件。我将利用一种新的活细胞传感器，该传感器我开发了它可以监视细胞周期依赖性激酶2（CDK2）活性，这是细胞周期进程的关键驱动力。细胞周期承诺以CDK2活性的积累为标志，而静态细胞缺乏CDK2活性。我的第一个目的是确定CDK抑制剂P21如何控制有丝分裂后的细胞立即积累CDK2活性并选择增殖性命运或关闭CDK2活性并关闭静态命运。我的第二个目标将探索DNA损伤导致细胞周期停滞，细胞如何从这种损伤和恢复循环中恢复的动力学以及一个细胞周期中的DNA损伤如何影响下一个周期中的增殖 - 降低决策。在我的第三个目标中，我试图了解生长因子信号如何调节细胞周期机制以驱动增殖以及如何将有丝分裂信号整合到上一个细胞周期的G2/m中，以影响细胞的增殖或静止命运。我有能力将上游信号转导事件与单个细胞中的增殖 - 散发结果联系起来，将为这个关键控制点提供宝贵的见解，并可能识别用于治疗癌症治疗的新靶标。